KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Return on Assets (2016 - 2025)

Historic Return on Assets for Vertex Pharmaceuticals (VRTX) over the last 16 years, with Q4 2025 value amounting to 0.16%.

  • Vertex Pharmaceuticals' Return on Assets rose 1800.0% to 0.16% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.16%, marking a year-over-year increase of 1800.0%. This contributed to the annual value of 0.16% for FY2025, which is 1900.0% up from last year.
  • Per Vertex Pharmaceuticals' latest filing, its Return on Assets stood at 0.16% for Q4 2025, which was up 1800.0% from 0.15% recorded in Q3 2025.
  • Over the past 5 years, Vertex Pharmaceuticals' Return on Assets peaked at 0.23% during Q1 2021, and registered a low of 0.04% during Q1 2025.
  • Its 5-year average for Return on Assets is 0.14%, with a median of 0.17% in 2023.
  • Over the last 5 years, Vertex Pharmaceuticals' Return on Assets had its largest YoY gain of 1800bps in 2025, and its largest YoY loss of -2200bps in 2025.
  • Over the past 5 years, Vertex Pharmaceuticals' Return on Assets (Quarter) stood at 0.18% in 2021, then rose by 6bps to 0.19% in 2022, then dropped by -15bps to 0.16% in 2023, then tumbled by -115bps to 0.02% in 2024, then surged by 754bps to 0.16% in 2025.
  • Its Return on Assets was 0.16% in Q4 2025, compared to 0.15% in Q3 2025 and 0.16% in Q2 2025.